The National Comprehensive Cancer Network (NCCN) released new guidelines on September 8th, 2020, which included updates to breast cancer risk management recommendations by gene as follows: - NBN – high-risk breast screening was removed as there is insufficient evidence to support high cancer risks
- BARD1 – added consideration for high-risk breast screening starting at age 40
- RAD51C & RAD51D – risks for triple negative breast cancer were broadened to include potential increase in female breast cancer risk
- BRCA1/2 – in men with gynecomastia, added consideration for annual mammogram at age 50 (or 10 years before earliest male breast cancer diagnosis in the family)
You can check out the full guidelines by creating a FREE account at: https://www.nccn.org/professionals/physician_gls/pdf/genetics_bop.pdf